RT Journal Article
SR Electronic
T1 Evaluation of Sample Pooling for Screening of SARS CoV-2
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.10.20123398
DO 10.1101/2020.06.10.20123398
A1 Mulu, Andargachew
A1 Alemayehu, Dawit Hailu
A1 Alemu, Fekadu
A1 Tefera, Dessalegn Abeje
A1 Wolde, Sinknesh
A1 Aseffa, Gebeyehu
A1 Seyoum, Tamrayehu
A1 Habtamu, Meseret
A1 Abdissa, Alemseged
A1 Bayih, Abebe Genetu
A1 Beyene, Getachew Tesfaye
YR 2020
UL http://medrxiv.org/content/early/2020/06/12/2020.06.10.20123398.abstract
AB Background The coronavirus disease (COVID-19) pandemic has revealed the global public health importance of robust diagnostic testing. To overcome the challenge of nucleic acid (NA) extraction and testing kit availability efficient method is urgently needed.Objectives To establish an efficient, time and resource-saving and cost-effective methods, and to propose an ad hoc pooling approach for mass screening of SARS-CoV-2Methods Direct clinical sample and NA pooling approach was used for the standard reverse transcriptase polymerase chain reaction (RT-PCR) test of the SARS CoV-2 targeting the envelop (E) and open reading frame (ORF1ab) genomic region of the virus. In this approach, experimental pools were created using SARS CoV-2 positive clinical samples spiked with up to 9 negative samples prior to NA extraction step to have a final extraction volume of 200 μL (maximum dilution factor of 10). Viral NA was also subsequently extracted from each pool and tested using the SARS CoV-2 RT-PCR assay.Results We found that a single positive sample can be amplified and detected in pools of up to 7 samples depending on the ct value of the original sample, corresponding to high, medium, and low SARS CoV-2 viral copies/reaction. However, to minimize false negativity of the assay with pooling strategies and with unknown false negativity rate of the assay under validation, we recommend poling of 4 in 1 using the standard protocols of the assay, reagents and equipment. The predictive algorithm indicated a pooling ratio of 4 in 1 was expected to retain accuracy of the test irrespective of the ct value (relative RNA copy number) of the sample spiked and result in a 237% increase in testing efficiency.Conclusions The approaches showed its concept in easily customized and resource-saving manner and would allow expanding of current screening capacities and enable the expansion of detection in the community.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated or analysed during this study are included in this articlectCycle thresholdCOVID-19Coronavirus disease 2019DNADeoxyribonucleic acidEEnvelopLODLimit of detectionMMMaster MixµlMicro literNANucleic acidORF1abOpen reading frameRT-PCRReverse transcriptase polymerase chain reactionRNARibonucleic acidSARS CoV-2Severe acute respiratory syndrome coronavirus 2